Contributor
Margaretta Colangelo is Co-founder and CEO of Jthereum an enterprise Blockchain company and President of U1 Technologies an enterprise software company. She has published over 300 articles on AI and DeepTech. Margaretta serves on the advisory board of the AI Precision Health Institute at the University of Hawaii Cancer Center. She is based in San Francisco.
The 5th edition of the Artificial Intelligence Index Report entitled Measuring Trends in Artificial Intelligence was released this week. The report, produced by the Stanford Institute for Human-Centered Artificial Intelligence (HAI), is …
Read More
“AI can learn to identify cells based on visual differences that are hardly accessible to the human eye and can continually improve, thanks to our capability to sort cells and …
Read More
“Our commitment is to provide the best possible care for our patients, and it is increasingly clear that AI-powered pathology can radically enhance diagnostic accuracy and treatment selection.” Dr. Brian …
Read More
“We are excited to spearhead research on the use of AI in the clinical setting. AI can potentially capture and make sense of complex image information in a multidimensional manner, …
Read More
“A few weeks is what most clinicians call ‘rapid’ when it comes to sequencing a patient’s genome and returning results.” Dr. Euan Ashley, professor of medicine, genetics and biomedical data …
Read More
This weekend the Riyadh Global Summit for Artificial Intelligence In Healthcare took place in The Kingdom of Saudi Arabia. Leading AI scientists, Pharma executives, and business leaders from around the …
Read More
This week the FDA approved Gleamer BoneView® AI software to detect fractures and traumatic skeletal injuries in the US. This is the first solution to receive FDA and CE clearance in this …
Read More
“It gives me great pleasure to announce that we have completed our first human in Phase 0 clinical trial and entered the full Phase 1 clinical trial with a once-a-day oral …
Read More
Researchers at National University of Singapore have developed a novel protocol using AI and inexpensive equipment to identify live cancer cells in less than 35 minutes with 95% accuracy. The ability to …
Read More
AI in Healthcare companies are making significant progress. We’ve reached the threshold of a new era where advanced technologies will improve the way we understand, treat, and prevent disease. In …
Read More